SCHEMBL420901

SCHEMBL420901

CC=C[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1117829 1.00
SCHEMBL420900 1.00
Bicarbonate SCHEMBL4299701 0.88 FBP1 (0.38)
Ethylene Glycol SCHEMBL23721619 0.86 ALDH1A1 (0.38)
SCHEMBL10528655 0.84 FBP1 (0.30)
SCHEMBL10909800 0.78
SCHEMBL13214996 0.78
SCHEMBL10909794 0.78
SCHEMBL2701677 0.76
SCHEMBL5957000 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240082408-A1 BILIRUBIN NANOPARTICLE, USE THEREOF, AND PREPARATION METHOD THEREFOR Bilix Co., Ltd. (KR) 2024-03-14 US claimed
US-11904019-B2 Bilirubin nanoparticle, use thereof, and preparation method therefor Bilix Co., Ltd. (KR) 2024-02-20 US claimed
US-11896681-B2 Particles comprising bilirubin derivative and metal Bilix Co., Ltd. (KR) 2024-02-13 US claimed
CN-116999578-A Ultrasonic contrast agent for diagnosis and treatment based on bilirubin derivative 株式会社毕丽斯 2023-11-07 CN claimed
EP-3750563-A1 BILIRUBIN DERIVATIVE-BASED DIAGNOSTIC AND THERAPEUTIC ULTRASOUND CONTRAST AGENT Bilix Co., Ltd. (KR) 2020-12-16 EP claimed
CN-111757758-A Ultrasonic contrast agent based on bilirubin derivative for diagnosis and treatment 株式会社毕丽斯 2020-10-09 CN claimed
US-20200230261-A1 PARTICLES COMPRISING BILIRUBIN DERIVATIVE AND METAL KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2020-07-23 US claimed
CN-111182926-A Particles comprising bilirubin derivatives and metals 株式会社毕丽斯 2020-05-19 CN claimed
EP-3622969-A2 PARTICLES COMPRISING BILIRUBIN DERIVATIVE AND METAL Bilix Co., Ltd. (KR) 2020-03-18 EP claimed
EP-3145020-B1 ELECTROLYTE FOR SECONDARY BATTERY AND SECONDARY BATTERY INCLUDING THE SAME SAMSUNG ELECTRONICS CO LTD (KR) 2019-10-09 EP claimed
CN-105199674-A Refrigerant composition Shandong huaan new material co ltd 2015-12-30 CN claimed
WO-2015099492-A1 BILIRUBIN NANOPARTICLE, USE THEREOF, AND PREPARATION METHOD THEREFOR 한국과학기술원 2015-07-02 WO claimed
US-7539006-B2 Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORPORATION (JP) 2009-05-26 US claimed
CN-100456398-C Electrolyte for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORP (JP) 2009-01-28 CN claimed
US-20070029529-A1 Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor KOMATSU AKIHIKO 2007-02-08 US claimed
US-20040245105-A1 Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor RUBYCON CORPORATION (JP) 2004-12-09 US claimed
CN-1529892-A Electrolyte for driving electrolytic capacitor and electrolytic capacitor 如碧空株式会社 2004-09-15 CN claimed
EP-1437749-A1 ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR Rubycon Corporation (JP) 2004-07-14 EP claimed
WO-2002034306-A1 SURFACE MODIFICATION OF ISLET MEMBRANES BY POLYMERIC GRAFTING METHODS MEDIPLEX CORP., KOREA (KR) 2002-05-02 WO claimed
US-4506098-A Process for the preparation of 2,6-dialkylaniline from 1-nitroalkene CHEVRON RESEARCH COMPANY (US) 1985-03-19 US claimed